The University of Chicago Header Logo

Connection

Michael Davidson to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications Michael Davidson has written about Clinical Trials, Phase I as Topic.
Michael Davidson
Connection Strength
0.092
Clinical Trials, Phase I as Topic
  1. Emerging low-density lipoprotein therapies: Targeting PCSK9 for low-density lipoprotein reduction. J Clin Lipidol. 2013 May-Jun; 7(3 Suppl):S11-5.
    View in: PubMed
    Score: 0.092
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.